Integral Derivatives’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-8,200
Closed -$278K 811
2017
Q4
$278K Buy
8,200
+1,400
+21% +$49K 0.01% 894
2017
Q3
$231K Buy
+6,800
New +$233K ﹤0.01% 969
2017
Q1
Sell
-88,600
Closed -$2.13M 1257
2016
Q4
$2.13M Buy
+88,600
New +$2.42M 0.04% 306
2015
Q4
Sell
-115,000
Closed -$3.13M 1127
2015
Q3
$3.13M Buy
115,000
+35,000
+44% +$959K 0.09% 196
2015
Q2
$2.2M Buy
80,000
+70,000
+700% +$1.69M 0.06% 295
2015
Q1
$214K Sell
10,000
-12,200
-55% -$208K ﹤0.01% 941
2014
Q4
$418K Hold
22,200
0.01% 970
2014
Q3
$486K Buy
22,200
+200
+0.9% +$5.34K 0.01% 986
2014
Q2
$710K Hold
22,000
0.01% 810
2014
Q1
$630K Sell
22,000
-2,600
-11% -$85.9K 0.01% 816
2013
Q4
$968K Buy
+24,600
New +$852K 0.01% 792

Other funds holding HLF

Integral Derivatives's HLF Position: Q3 2017 in Review

Integral Derivatives sold out of Herbalife (HLF) in Q3 2017, closing a stake of 8,400 shares — an estimated $288K sold.

Integral Derivatives first reported a position in HLF in Q4 2013 and held it in 4 quarters. The position peaked at $1.4M in Q4 2013. 193 funds tracked by Wall St. Rank hold HLF as of Q3 2017.

  • Integral Derivatives reported no remaining Herbalife position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 8,400 Herbalife shares in Q3 2017, an estimated $288K.
  • Integral Derivatives first reported a position in Herbalife in Q4 2013 and held it in 4 quarters.
  • Integral Derivatives's Herbalife position peaked at $1.4M in Q4 2013.
  • 193 funds tracked by Wall St. Rank held Herbalife as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.